Farmak International is an international pharmaceutical company working alongside partners as they navigate the needs of diverse healthcare markets for complex generic medicines.

What defines our role is not a single function. It is the way development, manufacturing, and regulatory capabilities come together to support reliable access to pharmaceutical products — in both established and evolving environments.

Based in Switzerland, Farmak International operates across regions and continents, including Europe, the Middle East, Africa, Central Asia, East Asia, and South America.

Our coordinated international team supports pharmaceutical distribution and commercialization in 60+ countries. And we do so while remaining close to healthcare partners and institutions on the ground.

From Development to Global Markets

Our full-cycle approach helps partners manage the product journey with greater clarity and fewer handovers. Pharmaceutical development, manufacturing, registration, and international market supply are connected into one continuous framework.

This is the practical value in each collaboration with Farmak International. Our partners work with a single international supplier across multiple stages.

By aligning documentation, licensing, and commercialization pathways early on, we ensure our partners can enter markets fully prepared. Within this full-cycle model, Farmak International acts as a pharmaceutical distributor supporting international healthcare markets.

Complex Generics Manufacturing Focus

Careful manufacturing and coordination always matter. Even more so when products are complex.

Our portfolio is built around specialty generics and complex pharmaceutical products, including long-acting injectables (LAIs), with a clear emphasis on hospital care and hospital supplier needs. That’s where manufacturing capabilities play a central role, supporting products that rely on advanced technologies. We are dedicated to assisting healthcare systems that rely on a steady supply of critical therapies.

By aligning manufacturing decisions with real-world needs, we help partners fill gaps and enrich their broader portfolios. Products are structured across multiple therapeutic areas, supporting a wide range of institutional healthcare requirements. This manufacturing-led portfolio strategy allows us to act as a dependable supplier for partners who place a lot of weight on stability and scalability.

A detailed overview of available pharmaceutical products is available in the product portfolio section.

EU GMP Manufacturing and Development

At the foundation of our operations lies EU GMP-certified manufacturing. Our production is combined with strong development and dossier capabilities, supporting specialty generics, sterile injectables, and advanced dosage forms.

The development expertise of Farmak International supports partners in very practical ways. With two R&D centers in Europe, we work on formulation development and dossier preparation. For our partnerships, it means the freedom to act swiftly and remain self-sufficient as products move from development to commercialization.

Rather than being confined to dictated checkpoints, we prefer to go beyond. Quality assurance and regulatory responsibility are embedded across development and manufacturing at every step. This integrated approach supports regulatory compliance and consistent product performance throughout international distribution networks.

Partnership Benefits for B2B Markets

Long-term collaboration, not transactional supply, shapes how we work with hospitals, distributors, and healthcare organizations. Our focus on B2B healthcare cooperation reflects this orientation.

Partners working with Farmak International benefit from:

• * access to registration-ready CTD dossiers;
• * flexibility to adapt documentation to local regulatory requirements;
• * smooth tech transfer and lifecycle support when needed;
• * proven track record of successful launches in 60+ countries;
• * customization of portfolio, documentation, and launch support to partner needs.

Beyond product supply, we engage through a full-cycle cooperation model.

It may include development support, licensing arrangements, contract manufacturing, and international distribution. This allows partners to engage at different stages of the product lifecycle, depending on strategic intent rather than fixed templates. These elements enable us to remain a reliable partner in complex pharmaceutical markets.

International Presence and Distribution

Consistency across borders requires more than reach. Pharmaceutical distribution at Farmak International is supported through a coordinated international presence, managed via 13 commercial offices across Europe, MEA, SEA, and CCA.

International Pharmaceutical Overview

What ties our activities together is a simple focus: helping partners navigate complexity with confidence.

By bringing EU GMP manufacturing, development expertise, and international commercialization into a single operating model, we support healthcare markets globally through specialty generics, sterile injectables, structured distribution, and long-term partnerships.